rosiglitazone has been researched along with carboplatin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alberta, JA; Bronson, R; Girnun, GD; Naseri, E; Qu, L; Spiegelman, BM; Szwaya, JD; Vafai, SB | 1 |
| Buckley, S; Chen, L; Chirieac, LR; Demetri, G; Drapkin, R; Force, J; Girnun, GD; Li, D; Mahmood, U; McNamara, K; Naseri, E; Padera, RF; Silvaggi, J; Spiegelman, BM; Upadhyay, R; Vafai, SB; Weissleder, R; Wong, KK | 1 |
| Frazier, SA; Guerrero, TA; McKemie, DS; Rodriguez, CO; Skorupski, KA | 1 |
| Allstadt Frazier, S; Guerrero, TA; Kass, PH; LaChapelle, H; McKemie, DS; Rodriguez, CO; Skorupski, KA | 1 |
1 trial(s) available for rosiglitazone and carboplatin
| Article | Year |
|---|---|
Phase I clinical trial of oral rosiglitazone in combination with intravenous carboplatin in cancer-bearing dogs.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Female; Hypoglycemic Agents; Injections, Intravenous; Male; Neoplasms; Rosiglitazone; Thiazolidinediones | 2014 |
3 other study(ies) available for rosiglitazone and carboplatin
| Article | Year |
|---|---|
Synergy between PPARgamma ligands and platinum-based drugs in cancer.
Topics: Antineoplastic Agents; Carboplatin; Cell Division; Drug Synergism; Ligands; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2007 |
Regression of drug-resistant lung cancer by the combination of rosiglitazone and carboplatin.
Topics: Animals; Antineoplastic Agents; Carboplatin; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Drug Therapy, Combination; ErbB Receptors; Genes, ras; Humans; Hypoglycemic Agents; Lung Neoplasms; Magnetic Resonance Imaging; Mice; Mice, Transgenic; PPAR gamma; Protein Kinase Inhibitors; Rosiglitazone; Thiazolidinediones; Uteroglobin | 2008 |
Evaluation of an extractionless high-performance liquid chromatography-tandem mass spectrometry method for detection and quantitation of rosiglitazone in canine plasma.
Topics: Animals; Antineoplastic Agents; Area Under Curve; Carboplatin; Chromatography, High Pressure Liquid; Dog Diseases; Dogs; Female; Half-Life; Male; Neoplasms; Rosiglitazone; Sensitivity and Specificity; Tandem Mass Spectrometry; Thiazolidinediones | 2011 |